K Harini,
K Girigoswami, M Vajagathali, D Bose… - Naunyn-Schmiedeberg's …, 2024 - Springer
Abstract Bupropion (Bpn), an FDA-approved NDRI (norepinephrine-dopamine reuptake
inhibitor), poses risks of seizures and liver failure due to its stimulant properties …